← Evidence map

ArticleClinical and translational discovery2022

A commentary on "PI3K-α/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron".

Sakthijothi Muthu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35942238